ボスニア・ヘルツェゴビナ - クロアチア語 - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

krka farma d.o.o. sarajevo - askorbinska kiselina, folna kiselina, kalcijumpantotenat, nikotinamid, piridoksin, retinol, riboflavin, tiamin, vitamin b12, vitamin d3, vitamin e - obložena tableta - 5000 i.j./1 tableta+ 400 i.j./1 tableta+ 60 mg/1 tableta+ 1.5 mg/1 tableta+ 1.7 mg/1 tableta+ 2 mg/1 tableta+ 6 µg/1 tableta+ 20 - 1 obložena tableta sadrži: 5000 iu vitamina a (u obliku retinol palmitata); 400 iu holekalciferola (vitamin d3); 60 mg askorbinske kiseline; 20 mg nikotinamida; 15 mg αtokoferil acetata (vitamin e); 10 mg kalcijumpantotenata; 2 mg piridoksin idrohlorida (vitamin b6); 1,7 mg riboflavina (vitamin b2); 1,5 mg tiamin nitrata (vitamin b1); 0,4 mg folne kiseline; 6 mcg cijanokobalamina (vitamin b12).

モンテネグロ - クロアチア語 - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

društvo za trgovinu, promet i usluge "farmegra" d.o.o. podgorica - cetilpiridinijum - lozenga - 1.2mg

モンテネグロ - クロアチア語 - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

društvo za trgovinu, promet i usluge "farmegra" d.o.o. podgorica - benzalkonijum hlorid - lozenga - 1mg

モンテネグロ - クロアチア語 - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

društvo za trgovinu, promet i usluge "farmegra" d.o.o. podgorica - cetilpiridinijum - lozenga - 1.2mg

モンテネグロ - クロアチア語 - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

dio stranog druŠtva "krka d.d. novo mesto" slovenija - predstavniŠtvo podgorica - cetilpiridinijum - lozenga - 1.2mg

クロアチア - クロアチア語 - HALMED (Agencija za lijekove i medicinske proizvode)

b. braun adria d.o.o., zagreb - otopina za ispiranje tijekom endoskopskih pretraga

欧州連合 - クロアチア語 - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - lamivudin - hepatitis b, kronični - antivirusni lijekovi za sustavnu uporabu - zeffix is indicated for the treatment of chronic hepatitis b in adults with: , compensated liver disease with evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active liver inflammation and / or fibrosis. početak liječenja lamivudinom mora biti samo u slučaju, ako se korištenje alternativnih antivirusnih agenata s višim genetski barijera nisu dostupni ili odgovarajući;, декомпенсированной bolesti jetre u kombinaciji s drugi agent bez križne rezistencije na lamivudin.

欧州連合 - クロアチア語 - EMA (European Medicines Agency)

merck europe b.v. - tepotinib hydrochloride monohydrate - karcinom, ne-malih stanica pluća - antineoplastična sredstva - tepmetko as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum-based chemotherapy.

欧州連合 - クロアチア語 - EMA (European Medicines Agency)

novartis europharm limited  - capmatinib dihydrochloride monohydrate - karcinom, ne-malih stanica pluća - antineoplastična sredstva - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

欧州連合 - クロアチア語 - EMA (European Medicines Agency)

viiv healthcare bv - lamivudin, зидовудин - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - combivir is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection.